The therapy is the latest to raise questions about how the FDA assesses drugs for devastating diseases, such as ALS and Alzheimer’s.
Desperate patients want a new ALS drug. The FDA is not sure it works.
The therapy is the latest to raise questions about how the FDA assesses drugs for devastating diseases, such as ALS and Alzheimer’s.